Clinical

Dataset Information

0

Study to Evaluate Mechanisms of Acquired Resistance to Panitumumab


ABSTRACT: This study is designed to evaluate the mechanism(s) of resistance to the anti-epidermal growth factor receptor (EGFR) antibody panitumumab given in combination with irinotecan in metastatic colorectal carcinoma (mCRC) patients with wild-type Kirsten rat sarcoma-2 virus oncogene (KRAS) tumor status at the time of initial diagnosis.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2071598 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2035328 | ecrin-mdr-crc
2012-10-19 | E-MTAB-923 | biostudies-arrayexpress
2016-01-12 | PXD003001 | Pride
| 2085360 | ecrin-mdr-crc
| 2111195 | ecrin-mdr-crc
| 2079859 | ecrin-mdr-crc
2015-12-25 | GSE75435 | GEO
| 2067755 | ecrin-mdr-crc
| 2109274 | ecrin-mdr-crc
| 2134496 | ecrin-mdr-crc